Poniard Pharmaceuticals Inc (PARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2010 | 03-2010 | 12-2009 | 09-2009 | 06-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,350 | 12,850 | 16,210 | 19,320 | 18,880 |
| Marketable Securities | 19,060 | 25,770 | 27,450 | 21,070 | 31,300 |
| Other current assets | 730 | 820 | 830 | 920 | 930 |
| TOTAL | $30,140 | $39,440 | $44,490 | $41,310 | $51,110 |
| Non-Current Assets | |||||
| PPE Net | 1,240 | 1,260 | 1,410 | N/A | 1,510 |
| Other Non-Current Assets | 7,030 | 7,390 | 7,720 | 8,040 | 8,360 |
| TOTAL | $8,270 | $8,650 | $9,130 | $8,040 | $9,870 |
| Total Assets | $37,280 | $46,970 | $52,440 | $49,640 | $59,820 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 540 | 1,230 | 840 | 820 | 2,020 |
| Accrued Expenses | 3,490 | 6,320 | 7,670 | 8,180 | 7,860 |
| TOTAL | $11,910 | $15,440 | $17,120 | $17,570 | $18,450 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,780 | 8,500 | 10,180 | 11,840 | 13,490 |
| TOTAL | $8,300 | $9,980 | $11,660 | $11,840 | $13,490 |
| Total Liabilities | $20,220 | $25,430 | $28,790 | $29,420 | $31,950 |
| Shareholders' Equity | |||||
| Common Shares | 960 | 940 | 840 | 690 | 690 |
| Retained earnings | -427,230 | -420,630 | -408,150 | -394,860 | -384,860 |
| Other shareholders' equity | 10 | -10 | -20 | 20 | -10 |
| TOTAL | $17,050 | $21,540 | $23,640 | $20,210 | $27,870 |
| Total Liabilities And Equity | $37,270 | $46,970 | $52,430 | $49,630 | $59,820 |